BBTX

16.3502.32%

Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics

Peter Kolchinsky and Rajeev Shah, who control RA Capital Management, L.P., disclosed beneficial ownership of 7,429,758 shares of Bambusa Therapeutics, Inc., equal to 14.6% of its common stock. Their Schedule 13D, dated Nov. 6, 2026, followed Bambusa’s Nov. 2 IPO and disclosed open-market purchases by the Fund on Oct. 30. The investors say they bought the shares for investment, not to change control, but may discuss Bambusa’s strategy and governance.

Investor Intent

The investors say they have no current plans to pursue changes covered by Schedule 13D’s specified actions. They may talk with Bambusa leaders, directors, shareholders and other parties about its operations, strategic direction, governance, capitalization, or possible business combinations and dispositions. RA Capital partner Derek DiRocco already serves on Bambusa’s board and will take part in regular board and management discussions as a director.

Investor's Background

RA Capital Management, L.P. provides investment management services to RA Capital Healthcare Fund, L.P. and RA Capital Nexus Fund III, L.P. Peter Kolchinsky and Rajeev Shah control the general partner of RA Capital and may be treated as beneficial owners of securities managed by the firm. RA Capital Healthcare Fund is a private investment vehicle, and RA Capital directs voting and investment decisions for the shares reported in this filing.

Original SEC Filing: Bambusa Therapeutics, Inc. [ BBTX ] - SCHEDULE 13D - Nov. 06, 2026

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.